<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 14 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Times New Roman","serif";
color:#1F497D;}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link="#0563C1" vlink="#954F72"><div class=WordSection1><p class=MsoNormal><span style='font-family:"Times New Roman","serif";color:#1F497D'>I agree with Jeff.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman","serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman","serif";color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in'><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Gnso-newgtld-wg-wt5 [mailto:gnso-newgtld-wg-wt5-bounces@icann.org] <b>On Behalf Of </b>Jeff Neuman<br><b>Sent:</b> Thursday, November 30, 2017 6:51 PM<br><b>To:</b> gnso-newgtld-wg-wt5@icann.org<br><b>Subject:</b> [Gnso-newgtld-wg-wt5] Comment on Paragraph 1 of the Scope of Terms of Reference<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>With respect to the Scope of the Terms of Reference, please keep in mind that this section refers only to what will be discussed. It is intended to make sure the right questions are being asked and the right topics are being covered. It should also be neutral in nature to allow all sides of an issue to be discussed. <o:p></o:p></p><p class=MsoListParagraph><o:p> </o:p></p><p class=MsoNormal style='margin-left:.5in'>Therefore, may I suggest a slight rewording of that first paragraph to the following:<o:p></o:p></p><p class=MsoListParagraph><o:p> </o:p></p><p class=MsoNormal><i><span style='font-family:"Arial","sans-serif";color:red'>Work Track 5 will focus on developing proposed recommendations regarding the treatment of geographic names at the top level (both in ASCII and IDN form), including whether such names require consent or non-objection from applicable governmental authorities, evaluation criteria and potential grounds for objection.</span></i><span style='font-family:"Arial","sans-serif";color:red'><o:p></o:p></span></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>This shorter rewording moves the consent or non-objection part up in the paragraph from where it is now. The new wording does not preclude any discussions on “approvals” nor does it implicitly endorse an approval-based model. It (hopefully) is neutral and by virtue of having the word “consent” in the paragraph will naturally lead to discussions on how one obtains consent or non-objection if required. <o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>In addition, the term consent is already in the Applicant Guidebook, so it is a term that we are all familiar with. And finally, according to <a href="http://www.thesaurus.com/browse/consent">http://www.thesaurus.com/browse/consent</a>, the term “Consent” is synonymous with, “approval, assent, authorization, permission, allowance, acquiescence”, etc.<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>This is being provided as a suggestion only to move forward the conversation. It is not being provided in any official capacity.<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Verdana","sans-serif";color:#0F9347'>Jeffrey J. Neuman</span></b><span lang=EN-GB style='color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#0F9347'>Senior Vice President </span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#4F4F4F'>|</span><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#C39209'>Valideus USA</span></b><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#C32830'> </span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#4F4F4F'>| </span><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#C32830'>Com Laude USA</span></b><span lang=EN-GB style='color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#4F4F4F'>1751 Pinnacle Drive, Suite 600<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#4F4F4F'>Mclean, VA 22102, United States<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#4F4F4F'>E: </span><u><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#00B050'><a href="mailto:jeff.neuman@valideus.com"><span style='color:#00B050'>jeff.neuman@valideus.com</span></a></span></u><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#595959'> or </span><u><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#00B050'><a href="mailto:jeff.neuman@comlaude.com"><span style='color:#00B050'>jeff.neuman@comlaude.com</span></a></span></u><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#00B050'> <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#4F4F4F'>T: +1.703.635.7514<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#4F4F4F'>M: +1.202.549.5079<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:#4F4F4F'>@Jintlaw<o:p></o:p></span></p><p class=MsoNormal><o:p> </o:p></p></div></body></html>